CD4 and neoplasm: Our previous report with syngeneic tumor models indicated that GzmB is critical for the ability of CD4+CD25+ regulatory T (Treg) cells to suppress antitumor immune responses mediated by CD8+ cytotoxic T cells and natural killer (NK) cells [14].